In gliomas, the SUMOylation of CDK6 inhibits ubiquitin‐mediated degradation of CDK6, stabilizes CDK6 protein, regulates the cell cycle, and ultimately drives the development of gliomas.20 This evidence concerns the gene CDK6 and glioma.